Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Farmers Insurance
Fuji
US Army
Queensland Health
QuintilesIMS
Harvard Business School
Daiichi Sankyo
Express Scripts

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,981,439

« Back to Dashboard

Which drugs does patent 7,981,439 protect, and when does it expire?

Patent 7,981,439 protects OXAYDO and is included in one NDA.

This patent has thirteen patent family members in six countries.
Summary for Patent: 7,981,439
Title:Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof
Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
Inventor(s): Kumar; Vijai (Morris Plains, NJ), Dixon; David (Woodside, NY), Tewari; Divya (Suffern, NY), Wadgaonkar; Dilip B. (Suffern, NY)
Assignee: Acura Pharmaceuticals, Inc. (Palatine, IL)
Application Number:12/231,136
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 7,981,439

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Egalet Us Inc OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Egalet Us Inc OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-002 Jun 17, 2011 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,981,439

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,409,616 Extended release opioid abuse deterrent compositions and methods of making same ➤ Subscribe
7,201,920 Methods and compositions for deterring abuse of opioid containing dosage forms ➤ Subscribe
9,492,443 Abuse deterrent compositions and methods of making same ➤ Subscribe
7,476,402 Methods and compositions for deterring abuse of opioid containing dosage forms ➤ Subscribe
8,637,540 Compositions for deterring abuse of opioid containing dosage forms ➤ Subscribe
8,101,630 Extended release opioid abuse deterrent compositions and methods of making same ➤ Subscribe
7,510,726 Methods and compositions for deterring abuse of opioid containing dosage forms ➤ Subscribe
8,822,489 Abuse deterrent compositions and methods of making same ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,981,439

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel 221018 ➤ Subscribe
Israel 175863 ➤ Subscribe
Spain 2637338 ➤ Subscribe
European Patent Office 2420225 ➤ Subscribe
European Patent Office 2402004 ➤ Subscribe
European Patent Office 1694260 ➤ Subscribe
Canada 2547334 ➤ Subscribe
Australia 2017239544 ➤ Subscribe
Australia 2015264950 ➤ Subscribe
Australia 2013206525 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Queensland Health
Covington
Novartis
US Department of Justice
Medtronic
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot